Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis

NCT07678203 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis (LN)
Chronic Kidney Disease
SGLT 2 Inhibitors
Systemic Lupus Erythematosus

Interventions

DRUG: Dapagliflozin (10Mg Tab) along with standard medical therapy
DEVICE: Proteinuria Quantification

Sponsor

Hospital Civil Juan I. Menchaca